Search - tctmd.com

Displaying 881 - 900 of 1865

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

The Voice of Interventional Echocardiography: Situations where TEE Provides Meaningful Value During TAVR (With Convincing Case Examples)

Presenter: Vinod H. Thourani, John G. Webb, Rebecca T. Hahn

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Repositionable and Retrievable HLT Meridian TAVR System

Presenter: Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

Presenter: Martin B. Leon

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A New Transcatheter Chordal-Leaflet Suspension System for DMR: The PIPLINE Trans-septal Concept

Presenter: Juan F. Granada, Martin B. Leon, Eberhard Grube

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Minimalist TAVR Strategy Should be the Default Approach Supported by Clinical Outcomes and Economic Benefits

Presenter: Vinod H. Thourani, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Anatomically Correct JenaValve TAVR System: AS and Pure AR Treatment

Presenter: Torsten P. Vahl

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Venus A-Valve and Venibri TAVR Systems: Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

The ACCURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Presentation The Structural Heart Disease Summit 2018

The ACURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Program Update: The ACCURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The ACURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Alexandre Abizaid

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

Presenter: Juan F. Granada, Martin B. Leon, Tarek Helmy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Raj Makkar

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Advertisement

The Voice of Interventional Echocardiography: Situations where TEE Provides Meaningful Value During TAVR (With Convincing Case Examples)

The Repositionable and Retrievable HLT Meridian TAVR System

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

A New Transcatheter Chordal-Leaflet Suspension System for DMR: The PIPLINE Trans-septal Concept

The Minimalist TAVR Strategy Should be the Default Approach Supported by Clinical Outcomes and Economic Benefits

The Anatomically Correct JenaValve TAVR System: AS and Pure AR Treatment

The Venus A-Valve and Venibri TAVR Systems: Better for Bicuspids and Dry Leaflet Technology

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

The ACURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Program Update: The ACURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content